Multicomponent Intervention Study- Blood Donors With High Cholesterol (DONATE-FH)
Lipid Metabolism Disorder
About this trial
This is an interventional prevention trial for Lipid Metabolism Disorder focused on measuring Blood Donors, High Cholesterol, LDL Cholesterol
Eligibility Criteria
Inclusion Criteria: Blood donors from Carter BloodCare with high cholesterol meeting MEDPED FH criteria Age 18 to 75 years Exclusion Criteria: Currently taking medication to lower cholesterol Taking any medication that can interact with statins Pregnancy Identified secondary cause of elevated lipids Chronic liver disease or significantly elevated liver function tests (> 3 times upper limit)
Sites / Locations
- UT Southwestern Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Other
Experimental
Control group (Usual care)
Intervention Group (Implementation strategy bundle)
This arm will receive standard notification that is usually provided by Carter describing need to review with donor's primary care physician the presence of high cholesterol
Along with standard high cholesterol notification from Carter BloodCare, this arm will receive Implementation strategy bundle (educational material regarding high cholesterol levels)